logo
New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model Have Equal or Better Clinical and Quality Outcomes and Less Healthcare Utilization

New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model Have Equal or Better Clinical and Quality Outcomes and Less Healthcare Utilization

Business Wire5 hours ago

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the publication of new peer-reviewed data examining the impact of gender differences of primary care physicians (PCPs) on patient outcomes, healthcare utilization and revenue using different Medicare payment models, specifically value-based care (VBC) and fee-for-service (FFS). Research was published in the May 16, 2025, issue of the JAMA Health Forum.
In the study, researchers identified nearly 900 PCPs, of whom 40% were women, at 15 practice groups across seven states who deliver care through agilon's VBC model. Researchers then examined claims data from approximately 225,000 Medicare Advantage (MA) patients who were treated by these physicians, as well as the corresponding Stars quality data from national and regional payors. When comparing men and women PCPs in the same practice groups, researchers found that patients managed by women PCPs in a VBC model experience equal or better clinical and quality outcomes and less healthcare utilization, and the women physicians earned more per patient.
'The reversal of the gender gap under value-based payment implies that these models may be better aligned with desirable practice patterns that are more common in women, like spending more face-to-face time with patients in office visits,' said study author Ishani Ganguli, MD, MPH, Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Specifically, researchers observed the following:
Outcomes: Senior patients managed by women PCPs experienced better key clinical outcomes, as evidenced by better hemoglobin A1C control and receipt of more eye exams for those with diabetes, compared to patients seen by men PCPs. Of note, similar patient outcomes were observed for blood pressure control and adherence to statin medication for cholesterol management between the two groups. In terms of quality scores, women PCPs had higher composite Stars quality scores, but lower provider rating scores than their men counterparts.
Utilization: While the number of primary care visits were similar between the two groups, visits to the emergency room (ER) and hospitalizations were substantially lower for patients seeing women PCPs compared to those seeing men PCPs.
Revenue: Compared to men PCPs in their own practice groups, women PCPs earned more per patient in the VBC model and similar amounts under the FFS model.
'As a woman physician, I believe VBC allows us the opportunity to leverage the relationships we develop with our patients, which correlates to improved outcomes, and the ability to be paid because of those important connections,' said study author Victoria DiGennaro, DO, Pioneer Physicians Network, Akron, OH. 'Our partnership with agilon health and implementation of its VBC model have been instrumental in enabling both of those to happen.'
agilon's VBC model, which puts the physician at the center, is known as the Total Care Model. The Total Care Model takes the same physicians, the same patients and the same payors, and moves them from the challenges of FFS into a total care relationship, which results in high-quality care and improved patient clinical and quality outcomes, lower healthcare costs and healthier communities. It encompasses long-term partnerships, a purpose-built platform and a Physician Network that helps physicians overcome obstacles and transition to VBC.
'In addition to agilon's Physician Network, another benefit of our partnership has been the focus on women physicians, which includes a Women Physician Leadership Council,' added Dr. DiGennaro. 'Many women physicians want to practice medicine as they were trained, while finding that critical work-life balance, and I'm proud to be a voice for them through my involvement on the Council.'
Study design
In this cross-sectional study, researchers examined PCPs with primary care specialties who participated in agilon's Total Care Model. A total of 872 PCPs (352 of whom were women) working in 15 practice groups in seven states (Ohio, Texas, New York, Pennsylvania, Connecticut, North Carolina and Michigan) were included, along with 223,810 MA patients. Women and men PCPs had similar education, years of experience and specialties.
There are several limitations to the study. First, results may not generalize beyond physicians who participate in risk arrangements. Second, MA patients represent only a portion of doctors' patient panels. And, finally, researchers cannot observe how individual practice groups translated MA payments to take-home wages (though comparing PCPs within the same practice groups mitigates this concern).
About agilon health
agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups and health systems transition to a value-based Total Care Model for their senior patients. agilon provides the technology, people, capital, process and access to a peer network of 2,200+ primary care physicians that allow its physician partners to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 30 diverse communities and is here to help more of our nation's leading physician groups and health systems have a sustained, thriving future. For more information, visit agilonhealth.com and connect with us on LinkedIn.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk Cuts Wegovy Deal, Triggers Massive Selloff in Hims & Hers
Novo Nordisk Cuts Wegovy Deal, Triggers Massive Selloff in Hims & Hers

Yahoo

timean hour ago

  • Yahoo

Novo Nordisk Cuts Wegovy Deal, Triggers Massive Selloff in Hims & Hers

June 23 - Shares of Hims & Hers Health (NYSE:HIMS) dropped about 30% on Monday after Novo Nordisk (NVO) said it would discontinue its collaboration with the telehealth firm, cutting off access to its weight loss drug, Wegovy, via NovoCare Pharmacy. Warning! GuruFocus has detected 5 Warning Sign with HIMS. The partnership began in late April after the U.S. Food and Drug Administration said Wegovy supply constraints had eased. Novo Nordisk then opened direct channels to Wegovy through select telehealth providers, including Hims & Hers. However, Novo Nordisk said its internal review raised red flags. The company alleged Hims & Hers failed to meet legal standards around compounded drugs, accusing it of offering mass-produced treatments under the pretense of personalized care. Executives at Novo Nordisk warned they would act against partners engaged in illegal compounding practices that risk patient safety. The company added that some compounded semaglutide products sourced by telehealth firms used unapproved ingredients from Chinese suppliers. Citing Brookings Institute research, Novo Nordisk noted that the FDA has neither approved the manufacturing practices nor reviewed the quality of semaglutide from these sources. The decision marks a sharp blow for Hims & Hers, which had leaned into weight-loss offerings as part of its growth strategy. This article first appeared on GuruFocus.

Dialysis Patient Citizens Applauds Texas Legislature for Passing Historic Bill Expanding Affordable Medigap Access for Dialysis and ALS Patients
Dialysis Patient Citizens Applauds Texas Legislature for Passing Historic Bill Expanding Affordable Medigap Access for Dialysis and ALS Patients

Yahoo

timean hour ago

  • Yahoo

Dialysis Patient Citizens Applauds Texas Legislature for Passing Historic Bill Expanding Affordable Medigap Access for Dialysis and ALS Patients

AUSTIN, Texas, June 23, 2025 /PRNewswire/ -- House Bill 2516 has become public law, a significant victory for Texans living with End-Stage Renal Disease (ESRD), or kidney failure, and Amyotrophic Lateral Sclerosis (ALS). The legislation, championed by Representative Ryan Guillen (R-TX-31), received overwhelming bipartisan support in the Texas State Legislature, passing the House with a 133-4 vote and the Senate unanimously. The law guarantees that ESRD and ALS patients under the age of 65 can access affordable Medigap insurance. Specifically, Medigap Plans A, B, and D will be available at the same premium rate as for those age 65, while the remaining plans will be capped at no more than 200% of the age 65 rate. Now, younger Texans suffering from ESRD and ALS no longer need to worry about Medicare's gaps in coverage. "Today is a landmark moment for dialysis and ALS patients across Texas," said Andrew Conkling, Board President for Dialysis Patient Citizens (DPC). "This law brings long-overdue relief to individuals who, until now, faced Medigap premiums as high as $1,700 per month simply because they were under 65. It restores fairness and makes critical coverage accessible to those who need it most." Previously, under-65 ESRD and ALS patients in Texas were priced out of Medigap plans due to prohibitively high premiums. HB 2516 ensures those patients can finally afford the supplemental insurance they rely on to cover the gaps in Medicare. DPC Patient Ambassador and Texas resident Patricia Benavidez-Patel shared her compelling story in support of the bill, stating: "I've lived with dialysis, and I've lived with the constant fear of bills I can't afford. This law gives patients like me a real chance; it gives me not only a chance to survive, but a chance to live without fear of medical debt." In addition, former DPC board member Natalie Zuniga, who recently passed away, wrote a letter to the editor in defense of Medigap access. Her voice continues to echo during this victory for the dialysis community, which she so fiercely supported. Dialysis Patient Citizens thanks Representative Guillen for his steadfast leadership, Governor Abbott and the Texas Legislature, and all the patient advocates who helped make this victory possible. View original content to download multimedia: SOURCE Dialysis Patient Citizens Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Lawmakers Seek to Close VA Loophole That Funnels Billions to Private Medicare Insurers
Lawmakers Seek to Close VA Loophole That Funnels Billions to Private Medicare Insurers

Wall Street Journal

timean hour ago

  • Wall Street Journal

Lawmakers Seek to Close VA Loophole That Funnels Billions to Private Medicare Insurers

A bipartisan group of lawmakers is aiming to close a loophole that allows large healthcare insurers to charge Medicare billions of dollars to cover veterans who get some of all of their treatment through the taxpayer-funded U.S. Department of Veterans Affairs health system. The group introduced legislation Monday in the House that would permit the VA to charge private health insurers in the Medicare Advantage system for medical care that it provides for the insurers' members. A similar measure is expected to be introduced later Monday in the Senate.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store